Log in
  • PO Box 450 Mawson ACT, 2607 Australia

  • 02 6260 4022

Tech Alert: Transition reminder –Valerian, Chelidonium, Chaparral - Liver warning statements

15 Jan 2024 11:54 AM | Anonymous member (Administrator)

In March 2023, the TGA introduced new label advisory statements for Valerian (Valeriana officininalis, Valerian dry, Valerian powder), Greater Celandine (Chelidonium majus), or Chaparral (Larrea tridentata), following a decision announced in December 2022.

The 12 month transition period for existing medicines that contain these ingredients is coming to an end. All existing products with these ingredients that are released for supply from 1 March 2024 must include the label advisory.

Please read this tech alert for details.

Copyright © 2019 Complementary Medicines Australia. All rights reserved.

Powered by Wild Apricot Membership Software